|
It was very difficult to initiate the deployment.They were eventually able to get it to deploy.It did not land exactly where they wanted it but it was acceptable.It was about 1 cm off.Patient outcome: did any unintended section of the device remain inside the patient¿s body? -no.If yes, please describe.Was the patient hospitalized or was there prolonged hospitalization? -no did the patient require any additional procedures due to this occurrence? -no.If yes, please describe.Did the product cause or contribute to the need for additional procedures? -no.If yes, please specify additional procedures and provide details.Has the complainant reported any adverse effects on the patient due to this occurrence? -no.Has the complainant reported that the product caused or contributed to the adverse effects? -no.Please specify adverse effects and provide details.Are images of the device or procedure available? n/a,yes,no -no.Did the patient have pre-existing conditions? n/a, yes, no -yes.If yes, please specify: -common iliac vein lesion.Please describe the native state of the vessel (i.E.Was the anatomy tortuous? was the vessel fibrotic?) n/a, tortuous, calcified, fibrotic, other -other.If other, please specify: -very narrow vessel 97 was a stent previously placed during previous procedures? n/a, yes, no -yes, on the other side, not cook, not today.98 was the device used percutaneously? n/a,yes,no -yes.99 where on the patient was the percutaneous access site? -groin.100 was the access site jugular or femoral? n/a, jugular, femoral other -femoral if other, please specify: -n/a.101 what disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other? -other.If other, please specify -chronic narrowing.102 was the lesion approached via contralateral or ipsilateral? n/a, contralateral, ipsilateral -ipsilateral.103 was pre-dilation performed ahead of placement of the stent? n/a, yes, no -no.104 what was the target location for the stent? -common iliac down to external.105 details of access sheath used (name, fr size, length)? -8 fr short sheath, unknown name.106 was the device flushed through both flushing ports before the procedure, as per ifu? n/a,yes,no -yes.107 details of the wire guide used (name, diameter, hyrdophyllic)? -.035 hydrophylic 108 was resistance encountered when advancing the wire guide to the target location? n/a, yes, no -no.109 was resistance encountered when advancing the delivery system to the target.Location? n/a, yes, no -no.110 if resistance was met, how did the physician address this? -n/a.111 did the tip of the delivery system cross the target location? n/a,yes,no -yes.112 did the user pull the handle towards the hub during deployment, per ifu? n/a,yes,no -yes.113 did the user push the hub during deployment? n/a, yes, no -yes because they were straining to pin and pull.114 did the user remove slack in the delivery system before deployment, per ifu? n/a, yes, no -yes.115 was the stent deployed smoothly / without resistance? n/a, yes, no -no.116 was the stent fully deployed in the patient? n/a, yes, no -yes.117 was the stent fully deployed before removing the delivery system from the patient? n/a, yes, no -yes.118 was post dilation performed after the placement of the stent? n/a, yes, no -yes was the delivery system damaged/kinked/twisted during deployment? n/a, yes, no -no.120 what intervention (if any) was required? -none.121 was the secondary intervention performed during the same procedure as the device failure or was it scheduled for another day? n/a, same procedure, another day -n/a.122 were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? n/a, yes, no -no.Please specify if yes.-n/a.
|